Immediapress- Pagina 399

– Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission  – Exclusive licensing and supply agreements have been granted to Medexus for

– Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission  – Exclusive licensing and supply agreements have been granted to Medexus for